IL-11 antibodies neutralize the cytokine IL-11, which is implicated in fibrotic diseases (e.g., idiopathic pulmonary fibrosis, liver cirrhosis) and aging .
IL-11 signals through the IL-11 receptor (IL-11Rα), activating pathways like ERK-mTORC1 and JAK-STAT3, promoting fibrosis and senescence . Antibodies block these pathways, mitigating tissue damage .
IL-11 antibodies (e.g., X203) reduce collagen deposition and epithelial-to-mesenchymal transition (EMT) in lung, liver, and kidney fibrosis models . For example:
Lung Fibrosis: X203 inhibits ERK/SMAD signaling, reducing myofibroblast activation .
Liver Fibrosis: Combined with dietary interventions, X203 reverses fibrosis in NASH models .
In mice, anti-IL-11 therapy (X203) extends median lifespan by 22–25% (120 → 155 weeks), reducing frailty, metabolic decline, and cancer incidence . Key effects include:
| Parameter | Wild-Type Mice | IL-11 Antibody-Treated Mice |
|---|---|---|
| Median Lifespan | 120 weeks | 155 weeks |
| Fat Mass (Old Age) | ↑ | ↓ |
| Lean Mass (Old Age) | ↓ | ↑ |
| Muscle Strength | ↓ | ↑ |
| Data from |
Ultra-sensitive assays (e.g., Simoa Planar Array) enable precise quantification of free IL-11 in plasma, critical for tracking therapeutic efficacy .
| Assay Platform | Lower Limit of Quantitation (LLOQ) | Application |
|---|---|---|
| Simoa Planar Array (SP-X) | 0.006 pg/mL | PK/PD modeling in mice/humans |
| Meso Scale Discovery | N/A | Epitope mapping |
FAQs for Researchers on IL-11 Antibody (X203 Clone) in Academic Research
Compiled from peer-reviewed studies, patents, and preprint data (2018–2025)
Early studies suggested IL-11 inhibits VSMC growth, but recent data show pro-proliferative effects in injury models .
Key factor: Recombinant human IL-11 (rhIL-11) acts as a competitive inhibitor of mouse IL-11, confounding earlier results .
Methodological fix: Use species-matched antibodies (e.g., X203 targets mouse IL-11) and validate via:
Epitope engineering: Target IL-11 residues 22–199 (X203’s binding site) to block receptor docking .
Mutagenesis strategies:
Conflicting finding: IL-11 inhibition reduces collagen in uninjured arteries (−32% vs. IgG) but has no effect on macrophage infiltration .
Resolution: